Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer
Ron Epelbaum(University of Bern), Abraham Kuten(Rambam Health Care Campus), David Faraggi(Carmel (Israel)), D. Gaitini(Technion – Israel Institute of Technology), Suheil Nasrallah(Technion – Israel Institute of Technology), Edward Rosenblatt(Technion – Israel Institute of Technology), Solly Mizrahi(Soroka Medical Center)
Cited by 115
Related Papers
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
|The Lancet|2002|1.7k
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
|New England Journal of Medicine|1997|1.6k
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
|New England Journal of Medicine|2015|1k
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
|The Lancet Oncology|2010|944
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480